140 related articles for article (PubMed ID: 16723192)
1. The relationship between crystalline methamphetamine use and methamphetamine dependence.
McKetin R; Kelly E; McLaren J
Drug Alcohol Depend; 2006 Dec; 85(3):198-204. PubMed ID: 16723192
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
[TBL] [Abstract][Full Text] [Related]
3. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of psychotic symptoms among methamphetamine users.
McKetin R; McLaren J; Lubman DI; Hides L
Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
[TBL] [Abstract][Full Text] [Related]
5. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
McKetin R; Kelly E
Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting.
Cunningham JK; Liu LM; Muramoto M
Addiction; 2008 Jul; 103(7):1174-86. PubMed ID: 18422822
[TBL] [Abstract][Full Text] [Related]
7. Impaired physical health among methamphetamine users in comparison with the general population: the role of methamphetamine dependence and opioid use.
McKetin R; Kelly E; McLaren J; Proudfoot H
Drug Alcohol Rev; 2008 Sep; 27(5):482-9. PubMed ID: 18608459
[TBL] [Abstract][Full Text] [Related]
8. The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system.
Topp L; Degenhardt L; Kaye S; Darke S
Drug Alcohol Rev; 2002 Dec; 21(4):341-8. PubMed ID: 12537703
[TBL] [Abstract][Full Text] [Related]
9. Can the severity of dependence scale be usefully applied to 'ecstasy'?
Bruno R; Matthews AJ; Topp L; Degenhardt L; Gomez R; Dunn M
Neuropsychobiology; 2009; 60(3-4):137-47. PubMed ID: 19893331
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
[TBL] [Abstract][Full Text] [Related]
11. Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents.
Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
J Adolesc Health; 2006 Sep; 39(3):374-80. PubMed ID: 16919799
[TBL] [Abstract][Full Text] [Related]
12. The bioavailability of intranasal and smoked methamphetamine.
Harris DS; Boxenbaum H; Everhart ET; Sequeira G; Mendelson JE; Jones RT
Clin Pharmacol Ther; 2003 Nov; 74(5):475-86. PubMed ID: 14586388
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine use among Australian workers and its implications for prevention.
Roche AM; Pidd K; Bywood P; Freeman T
Drug Alcohol Rev; 2008 May; 27(3):334-41. PubMed ID: 18368616
[TBL] [Abstract][Full Text] [Related]
14. Mephedrone use among same-sex attracted young people in Sydney, Australia.
Lea T; Reynolds R; De Wit J
Drug Alcohol Rev; 2011 Jul; 30(4):438-40. PubMed ID: 21450044
[TBL] [Abstract][Full Text] [Related]
15. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
16. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25.
Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
Addict Behav; 2007 May; 32(5):1003-15. PubMed ID: 16920275
[TBL] [Abstract][Full Text] [Related]
17. Substance initiation sequences among Taiwanese adolescents using methamphetamine.
Yen CF; Yang YH; Ko CH; Yen JY
Psychiatry Clin Neurosci; 2005 Dec; 59(6):683-9. PubMed ID: 16401244
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of methamphetamine use and harm in Australia.
Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
[TBL] [Abstract][Full Text] [Related]
19. Treatment response by primary drug of abuse: does methamphetamine make a difference?
Luchansky B; Krupski A; Stark K
J Subst Abuse Treat; 2007 Jan; 32(1):89-96. PubMed ID: 17175402
[TBL] [Abstract][Full Text] [Related]
20. Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sample.
Christian DR; Huber A; Brecht ML; McCann MJ; Marinelli-Casey P; Lord RH; Reiber C; Lu TH; ; Galloway GP
Subst Use Misuse; 2007; 42(14):2207-22. PubMed ID: 18098001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
